Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial Saghar Barati; Hossein Amini; Zargham Hossein Ahmadi; Alireza Dastan; Babak Sharif Kashani; Raha Eskandari; Farzaneh Dastan;

Edoxaban Treatment in routiNe clinical prActice in patients with non-valvular Atrial Fibrillation (ETNA-AF) in Iberia: Baseline data Pedro Monteiro;

Eligibility for extended antithrombotic therapy for secondary prevention of acute coronary syndrome Daniel Faria; Miguel Santos; Sérgio Bravo Baptista; João Ferreira; Paulo Leal; Pedro Farto e Abreu; Carlos Morais;